产品详情
简单介绍：
Anti-FGD3抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-FGD3抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-FGD3
Cat. Number:
Anti-FGD3抗体KL-16079R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
FGD1 gene mutations result in faciogenital dysplasia (FGDY, Aarskog-Scott syndrome), an X-linked developmental disorder that adversely affects the formation of multiple skeletal structures. FGD1 maps to human chromosome Xp11.21
Anti-FGD3抗体and shares a high degree of sequence identity with the FGD2 (6p21.2) and the FGD3 (9q22.31) proteins. FGD1 encodes a guanine nucleotide exchange factor that specifically activates the Rho GTPase Cdc42. FGD2 is present in several diverse tissues during embryogenesis, suggesting a role in embryonic development. FGD3 stimulates fibroblasts to form filopodia, which are Actin microspikes formed upon the stimulation of Cdc42. All FGD family members contain equivalent signaling domains and a conserved structural organization, which strongly suggests that these signaling domains form a canonical core structure for members of the FGD family of RhoGEF proteins. These proteins control essential signals required during embryonic development.
Also known as:
Faciogenital dysplasia 3; FGD1 family,
Anti-FGD3抗体member 3; FGD3; FGD3_HUMAN; FYVE; FYVE, RhoGEF and PH domain containing 3; FYVE, RhoGEF and PH domain containing protein 3; RhoGEF and PH domain-containing protein 3; ZFYVE5; Zinc finger FYVE domain containing protein 5; Zinc finger FYVE domain-containing protein 5.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
Anti-FGD3抗体
●
Immunogen: KLH conjugated synthetic peptide derived from human FGD3.
●
Predicted Molecular Weight: 79kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-FGD3抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-FGD3抗体
Optimal working dilutions must be determined by the end user.
kl278Ga01 踝蛋白(TLN)多克隆抗体 Polyclonal Antibody to Talin (TLN)
kl278Hu01 踝蛋白(TLN)多克隆抗体 Polyclonal Antibody to Talin (TLN)
kl278Mu01 踝蛋白(TLN)多克隆抗体 Polyclonal Antibody to Talin (TLN)
kl280Hu01 钙联蛋白(CNX)多克隆抗体 Polyclonal Antibody to Calnexin (CNX)
kl281Ga01 B-细胞激活因子受体(BAFFR)多克隆抗体 Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR)
kl281Hu01 B-细胞激活因子受体(BAFFR)多克隆抗体 Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR)
kl281Mu01 B-细胞激活因子受体(BAFFR)多克隆抗体 Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR)
kl284Ga01 肝素辅因子Ⅱ(HCⅡ)多克隆抗体 Polyclonal Antibody to Heklin Cofactor II (HCII)
kl284Hu01 肝素辅因子Ⅱ(HCⅡ)多克隆抗体 Polyclonal Antibody to Heklin Cofactor II (HCII)
kl284Mu01 肝素辅因子Ⅱ(HCⅡ)多克隆抗体 Polyclonal Antibody to Heklin Cofactor II (HCII)
kl284Ra01 肝素辅因子Ⅱ(HCⅡ)多克隆抗体 Polyclonal Antibody to Heklin Cofactor II (HCII)
kl284Rb51 肝素辅因子Ⅱ(HCⅡ)多克隆抗体 Polyclonal Antibody to Heklin Cofactor II (HCII)
kl292Ga01 α-胞衬蛋白(SPTAN1)多克隆抗体 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl292Hu01 α-胞衬蛋白(SPTAN1)多克隆抗体 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl292Mu01 α-胞衬蛋白(SPTAN1)多克隆抗体 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl292Ra01 α-胞衬蛋白(SPTAN1)多克隆抗体 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl293Bo01 谷氨酸脱氢酶(GDH)多克隆抗体 Polyclonal Antibody to Glutamate Dehydrogenase 1 (GDH)
kl293Hu01 谷氨酸脱氢酶(GDH)多克隆抗体 Polyclonal Antibody to Glutamate Dehydrogenase 1 (GDH)
kl293Mu01 谷氨酸脱氢酶(GDH)多克隆抗体 Polyclonal Antibody to Glutamate Dehydrogenase 1 (GDH)
